Grants and Contributions:
Title:
Improvements to bioprinted pancreatic and liver tissues for clinical applications
Agreement Number:
997886
Agreement Value:
$841,683.00
Agreement Date:
Sep 1, 2022 - Oct 31, 2023
Description:
This project will support the firm to achieve key development and regulatory milestones for their bioprinted pancreatic tissue therapeutic for Type 1 Diabetes to advance to final IND-enabling studies, and to demonstrate their 3D bioprinting technology is a biomanufacturing platform by showing efficacy of bioprinted liver tissues in multiple liver diseases.
Organization:
National Research Council Canada
Expected Results:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Location:
Vancouver, British Columbia, CA V6P 6P2
Reference Number:
172-2022-2023-Q3-997886
Agreement Type:
Contribution
Report Type:
Grants and Contributions
Recipient Business Number:
830167839
Recipient Type:
For-profit organization
Additional Information:
This agreement has been amended 1 time(s). The total amended value is 166,500 dollars.
Amendment Date
Sep 25, 2023
Recipient's Operating Name:
Aspect Biosystems
Recipient's Legal Name:
Aspect Biosystems Ltd.
Federal Riding Name:
Vancouver Quadra
Federal Riding Number:
59039
Program:
Industrial Research Assistance Program – Contributions to Firms
Program Purpose:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Coverage:
IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation.
NAICS Code:
541710
Amendments: